Xianzhu Yang
- Biomaterials top 0.1%
- Nanoparticle-Based Drug Delivery 54
- Biomedical Engineering top 0.2%
- Nanoplatforms for cancer theranostics 76
- Graphene and Nanomaterials Applications 17
- Pharmaceutical Science top 1%
- Molecular Biology top 2%
- RNA Interference and Gene Delivery 40
- Advanced biosensing and bioanalysis techniques 27
- Materials Chemistry top 2%
- Advanced Nanomaterials in Catalysis 14
-
- Immunotherapy and Immune Responses 18
-
- Dendrimers and Hyperbranched Polymers 11
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of the American Chemical Society (3 papers)Advanced Materials (3 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Xianzhu Yang
148 papers receiving 10.2k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Biomaterials 3.8k
- Biomedical Engineering 5.7k
- Pharmaceutical Science 393
- Molecular Biology 3.7k
- Materials Chemistry 2.5k
Countries citing papers authored by Xianzhu Yang
This map shows the geographic impact of Xianzhu Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianzhu Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianzhu Yang more than expected).
Fields of papers citing papers by Xianzhu Yang
This network shows the impact of papers produced by Xianzhu Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianzhu Yang. The network helps show where Xianzhu Yang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xianzhu Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 2 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 24 | |
| 7 | 2024 | 7 | |
| 8 | 2024 | 1 | |
| 9 | 2023 | 20 | |
| 10 | 2023 | 28 | |
| 11 | 2023 | 10 | |
| 12 | 2022 | 33 | |
| 13 | 2022 | 8 | |
| 14 | 2020 | 70 | |
| 15 | 2020 | 52 | |
| 16 | 2020 | 19 | |
| 17 | 2019 | 41 | |
| 18 | 2019 | 45 | |
| 19 | 2017 | 45 | |
| 20 | 2015 | 87 |
About Xianzhu Yang
Xianzhu Yang is a scholar working on Biomaterials, Biomedical Engineering and Immunology, having authored 156 papers that have together received 10.3k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (76 papers), Nanoparticle-Based Drug Delivery (54 papers), RNA Interference and Gene Delivery (40 papers), Advanced biosensing and bioanalysis techniques (27 papers), Immunotherapy and Immune Responses (18 papers), Graphene and Nanomaterials Applications (17 papers), Advanced Nanomaterials in Catalysis (14 papers) and Dendrimers and Hyperbranched Polymers (11 papers). The work is most often cited by research in Biomaterials (3.8k citations), Biomedical Engineering (5.7k citations) and Pharmaceutical Science (393 citations). Xianzhu Yang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Jun Wang, Jin‐Zhi Du, Dongdong Li, Yucai Wang, Song Shen, Ziyang Cao, Cong‐Fei Xu, Chunyang Sun, Menghua Xiong and Chengqiong Mao. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Advanced Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.